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SUMMARY
Patient`s age is an important factor in orthodontic treatment. There are many studies about 
bone aging from the aspects of osteoporosis and other bone diseases. Both, aging and osteo-
porosis are associated problems and have a great importance in relation to their incidence. 
But not only osteoporosis or other bone related diseases are issue for many studies, because 
the knowledge of bone pathophysiology  and diagnostics with signaling molecules makes it 
possible to predict treatment outcome and specifi c cell targeted pharmacology. In recent years 
immunohistological studies had become very popular in all fi elds of medicine including ortho-
dontics, too. The question we tried to answer in this literature mini-review was - what kind of 
immunohistological studies were done from the aspect of bone aging in relation to patient`s 
age and orthodontic treatment? 
Search on Cochrane Library, PubMed, Science Direct, and DynaMed data bases by keywords: 
Alveolar bone aging, RANK, RANKL, OPG, MMP-1, MMP-8, IL-1, IL-6, TNF-α, TNF-β, and 
BM, resulted with 147 full-text articles; from them 90 met the criteria, 30 were reviews, and 
only in 22 articles from 60 bone aging from the aspect of signaling molecules were discussed. 
Interestingly, only 2 articles (Cei 2006 and Zhang 2003) were related to alveolar bone, and none 
studied it from the orthodontic point of view. Patient`s age plays an important role in orthodontic 
treatment, because of the bone response to mechanical loading. It is in accordance to clinical 
studies, or alike, that tooth movement in younger patient occurs much faster than in adults, but 
the question which factors are responsible for the process still remains.
Key words: Alveolar bone aging, RANK, RANKL, OPG, MMP-1, MMP-8, IL-1, IL-6, 
TNF-α, TNF-β, BMP.
  Stomatologija, Baltic Dental and Maxillofacial Journal, 12: 99-104, 2010
1Department of Orthodontics, Institute of Stomatology, Riga Stra-
dins University, Riga, Latvia
2Institute of Anatomy, Riga Stradins University, Riga, Latvia
Maris Grzibovskis1 – D.D.S
Mara Pilmane2 – Dr. med., Dr. hab. med.
Ilga Urtane1 – D.D.S., Dr. med., prof.
Address correspondence to Dr. Maris Grzibovskis, 20 Dzirciema 
Street, Riga, Latvia, LV 1007.
E-mail address: mgmaris@inbox.lv
INTRODUCTION
Cellular aging is a process involving progres-
sive loss of genetic materials, accumulation of 
metabolic wastes, activation of aging genes and de-
activation of longevity genes. In all somatic cells of 
mammals occurs such cellular effects as cessation of 
proliferation, loss of normal function, and initiation 
of apoptosis, commonly expressing in aging of skin, 
immune disorders (such as AIDS, diabetes, macular 
degeneration), Alzheimer’s disease, atherosclerosis, 
and muscular dystrophy. While studies on progres-
sive accumulation of deleterious materials in cells 
have been one main focus of aging studies in the 
past decades, searching for genes switched on or 
off by mutation and deletion during aging has never 
stopped [11].
Aging is associated with marked changes in 
multiple organ systems, including bone. In humans, 
bone mineral density peaks between ten and nineteen 
years of age, with continued increase in bone mineral 
content until thirty to thirty-fi ve years of age [8].
Different metabolic parameters also have been 
studied in the liver by using primary cultures of 
hepatocytes from aged rats, such as ATP (adenosine 
triphosphate) production and oxidative stress mark-
ers. A reduction of the former and an increase of the 
later have been detected with aging [19].
Once the adult`s skeleton has been formed by 
modeling, the formation of new bone at new sites; 
this process becomes relatively unimportant; and re-
modeling or the removal and replacement of bone at 
the same site, predominates. Remodeling is most ac-
tive in trabecular bone, where Howship’s lacunae are 
formed by osteoclastic bone resorption and replaced 
by osteoblastic bone formation. The same process 
occurs more slowly in the cortex, and is known as 
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age, the balance tips towards bone resorption, result-
ing in a net loss of bone mass. This makes the)bone 
mass as a valuable marker refl ecting the aging [21].
OSTEOGENESIS
Bone is a dynamic multifunctional organ that 
is comprised of a structural framework of calcifi ed 
matrix containing populations of many cell types 
including chondrocytes, osteoblasts, osteocytes, 
osteoclasts, endothelial cells, monocytes, macro-
phages, lymphocytes, and hematopoeitic cells. Bone 
tissue is constantly being remodeled throughout life 
in response to hormonal signals, paracrine and au-
tocrine factors, and physical stresses. The structure 
of bone is formed, maintained and reformed by the 
collective action of cells that produce and mineralize 
bone matrix, and degrades it. These cells are termed 
osteoblasts and osteoclasts [7].
Far from the rigid, static structure that bone 
might be envisioned to be, the skeleton is in a state of 
constant degradation and reconstruction. Two of the 
major cell types of bone, osteoblasts and osteoclasts, 
are responsible for this continuous remodeling[18].
Osteoblasts are mononucleated cells originated 
from mesenchymal stem cells. At bone formation sites 
they produce and actively secrete osteoid consisting 
mainly of type I collagen and other proteins. Osteoid 
forms the bone matrix and under normal conditions 
is mineralized with hydroxyapatite to form the struc-
tural framework of bone. Osteoblasts maintain a high 
activity alkaline phosphatase and produce a number 
of regulatory effectors including prostaglandins, cyto-
kines and growth factors stimulating bone formation 
or resorption [7].
Osteoclasts are the cells responsible for bone re-
sorption. They are large multinucleated cells formed 
by the fusion of mononuclear hematopoietic precur-
sors brought to the bone through the vasculature. 
Active osteoclasts reside on the mineralized surface 
of the bone where they produce and release lysosomal 
enzymes, protons, and free radicals into the space in 
contact with the bone. These products dissolve the 
mineral and degrade the bone matrix. Osteoclastogen-
esis is regulated by a number of cytokines, growth 
factors, and eicosanoids [7]. 
Usually the amount of bone removed by the os-
teoclasts is equal to the amount of bone formed by the 
osteoblasts and persistent bone mass is maintained. 
However, this is not the case during aging. Increased 
bone resorption and/or decreased bone formation can 
lead to the bone loss. Based on a number of histomor-
phometric studies performed on iliac crest biopsies, a 
decrease in bone formation seems to be the principal 
Haversian remodeling; nevertheless, most cortical 
bone in adults is composed of cylindrical osteons 
formed by this process [16]. 
Aging is thought to be a contributing factor 
compromising the regenerative potential of bone. 
An age-related decrease in the number of osteogenic 
progenitor cells seen in animal models and in man 
may be one of the underlying mechanisms. In vitro 
fi ndings based on explanted cultures from rabbit peri-
osteum showed that the cambium layer, as well, as the 
potential of the cells to differentiate into chondrocytes 
are diminished with increasing age. In addition, the 
percentage of osteogenic cells within the bone mar-
row decreases with age. This may explain why the 
osteogenic potential of bone marrow samples from 
adult animals is poorer than that of marrow prepara-
tions derived from young littermates. The lower num-
ber of osteogenic cells at sites of bone regeneration 
and the impaired capacity of blood vessel formation 
are causal factors that can provide information about 
the mechanisms of compromised bone regeneration 
in elderly individuals [4].
Although there is thought to be a period of 
stability after completion of growth, during which 
time there is neither gain nor loss of skeletal mass 
from any surface of bone, ageing probably begins 
when growth ceases. BMD (bone mineral density) 
decreases at the spine and proximal femur in women 
before menopause. Bone is lost during the early adult 
years in men and in women because negative basic 
multicellular unit balance may begin at this time, in 
the third decade, well before menopause in women. 
The negative balance probably is the result of an early 
reduction in bone formation within each individual 
unit, and not due to an increase in the focal resorptive 
removal of bone. The hormonal and cellular factors 
responsible for the fall in bone formation early in life 
are unknown. Whether loss of bone is an appropriate 
response to reduced loading in a less active person, 
or an abnormality produced by reduced osteoblast 
lifespan, increased osteoclast lifespan, or abnormal 
osteocyte mechanical signaling is uncertain, but the 
effect is the same – bone loss and structural damage 
[17].
Although there is not a single defi nitive biologi-
cal marker that can be used for quantifying the rate 
of aging, the change of aging rate in mice can be 
revealed by quantitative measurement of a group of 
aging-related traits. Lifespan unquestionably is the 
most important trait refl ecting the rate of aging [21].
In the period from childhood to adulthood, the 
bone formation activity is higher than bone resorption 
activity, which results in a net increase of bone mass. 
At advanced periods of age, or particular periods of 
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pathophysiological mechanism responsible for age-
related decreased bone mass [3].
Osteocytes are the most abundant and evenly 
distributed, longest-living, and best-connected cell 
types in the mineralized matrix. However, it is the 
cannicular system through which these osteocytes 
communicate. Radiating dendritic processes from 
each osteocyte are extensive and run through the 
canaliculi, similar to dendritic processes in other 
systems. Solute transport through the bone lacunar–
canalicular system is believed to be essential for 
osteocytes` survival and function. However, this is 
not the only method of signaling these cells utilize. 
Osteocyte apoptosis can infl uence the mechanosen-
sory function of the osteocyte network. There are not 
enough data demonstrating the relationship between 
mechanical loading and sensing of these cells, it is 
thought that through interstitial fl uid osteocyte activ-
ity is triggered and also cell-signaling molecules and 
nutrient waste products. The highly interconnective 
system appears to be one reason why osteocytes are 
responsive to mechanical strain, as well as translat-
ing that strain accordingly to the intensity of strain 
signals. Mechanical strain is translated in vivo either 
as deformation of the extracellular matrix or as fl uid 
shear stress along the cells indicating that osteo-
cytes have close contact with the bone matrix. This 
mechanical sensor ability also has been indicated 
in the mechanosensing process, where osteocytes 
directly sense the deformation of the substrate they 
are attached with. Osteocytes make contact with the 
extracellular matrix through attachment points that 
colocalize with vinculin. This connection is important 
in translating mechanical strain from extracellular 
signals into intracellular messages [6].
BONE AGING AND OSTEOPOROSIS
Human aging is associated with bone loss leading 
to bone fragility and increased risk of fractures and 
osteoporosis. Osteoporosis is one of the most preva-
lent and serious diseases, it affects the elderly popula-
tion and is a signifi cant problem of the public health. 
The cellular and molecular causes of age-related bone 
loss are currently intensive topics of investigation 
with the aim of identifying new approaches to prevent 
and treat osteoporotic bone loss [3].
The usual description of the pathogenesis of 
osteoporosis and fragility fractures is that there are 
four major elements. 
1. Genetic and lifestyle factors that infl uence 
the ability to achieve peak bone mass and strength 
during childhood and adolescence. A large number 
of polymorphisms of genes that can infl uence bone 
mass and strength have been identifi ed now, but with 
the exception of a few single gene disorders such as 
osteogenesis imperfecta and the osteoporosis-pseudo-
glioma syndrome, the individual genetic differences 
generally contribute only a small amount of variation. 
Clearly osteoporosis is a polygenic disorder that may 
involve hundreds of different genetic contributions. 
There is epidemiologic evidence for substantial ef-
fects of nutrition and lifestyle on peak bone mass 
and on fracture risk, not only during childhood and 
adolescence, but even during gestation [2]. 
2. Fast loss of  the bone mass and microarchitec-
tural deterioration due to increased bone resorption 
occurs at the menopause due to estrogen defi ciency. 
In men defi ciency of estrogen and androgen also 
may contribute with aging. In older individuals, 
decreased intakes of calcium, low levels of vitamin 
D, and secondary hyperparathyroidism are impor-
tant factors. While there are some differences in the 
skeletal effects of estrogen defi ciency and calcium 
and vitamin D defi ciency, the overlap is suffi cient 
so that we no longer attempt to distinguish between 
“postmenopausal” and “senile” osteoporosis. 
3. An inadequate bone formation occurs during 
remodeling. The process may begin even in very 
young people; and presumably involve a failure of 
cells of the osteoblastic lineage to replicate, differ-
entiate and form a mineralized matrix as effectively 
as they did in younger individuals. Defi ciency of 
nutrition and growth factors have been implicated but 
their relative importance is not known. In addition, 
there may be accelerated programmed cell death – 
apoptosis of osteoblasts and osteocytes with aging. 
This is known to occur when glucocorticoids are 
administrated or when growth factors and their signal 
transduction pathways are impaired. Estrogen defi -
ciency may also play a role in the impairment of bone 
formation. Thus absolute rates of bone formation are 
increased at the menopause due to the increase in the 
number of remodeling sites, there is an imbalance, 
with more resorption than formation, leading to rapid 
(resulting with following/forthcoming)  bone loss. 
4. The risk of falling may be increased by neu-
romuscular impairment or drugs, that cause hypoten-
sion or impair balance. Immobilization can lead to 
both through impaired neuromuscular function and 
also to increased bone resorption and decreased bone 
formation [16]. 
In the modern era, many biologic functions ac-
quired during evolution have become maladaptive. 
This shift is in part attributable to dramatic changes 
in our living environment as well, as the sudden in-
crease of human lifespan during the past century. In 
majority of western cultures, people are living well 
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into post-reproductive senescence. Obesity, diabetes, 
Alzheimer’s disease, and atherosclerosis are ex-
amples of diseases of modernity that are attributable 
to modern life circumstances or that are unmasked 
during senility, an evolutionarily naive life epoch. The 
emergence of osteoporosis as a modern disease may 
be an example of this phenomenon [21]. According to 
this view an intervention to prevent their formation by 
the administration of antioxidants constitutes a major 
therapy for the amelioration of the aging process and 
age-associated diseases [12].
Despite all the pathogenetic mechanisms men-
tioned above, skeletal tissue remains viable, meta-
bolically active, and responsive to mechanical forces, 
hormones and other regulatory factors during the 
lifetime. Hence it is useful to assess the factors that 
result in impaired cellular function the skeleton and 
to attempt reverse them [17].
CYTOKINES, GROWTH AND APOPTOTIC 
FACTORS
The remodeling process involves four following 
steps: activation, resorbtion, reversal, and formation. 
1. Activation. The initiation of osteoclastic bone 
resorption depends on the interaction between cells 
of the osteoblastic and hematopoietic lineages [17]. A 
progressive reduction of hematopoietic tissue mass is 
observed with aging. The great majority of bone mar-
row areas show hematopoietic activity at birth, but 
starting from childhood a progressive fatty replace-
ment of active marrow areas in the long bones takes 
place. These fi ndings suggest that aging is associated 
with changes in the dynamics of hemopoietic stem 
and progenitor cell compartments which, although 
functionally irrelevant in healthy individuals, may 
infl uence the bone marrow response to pathologic 
events [15]. Recent studies analyzed human BMSCs 
(blood mesenchymal stem cells) stem/progenitor 
characteristics, i.e. the ability to retain the differen-
tiation potential, during in vitro culture expansion. 
The results convinced that, as a population, BMSCs 
progressively lost their differentiation potential in 
vitro and bone-forming effi ciency in vivo during the 
expansion period [13]. In addition, although normal 
fibroblasts function to maintain the intercellular 
matrix, senescent fi broblasts secrete collagenase 
and other matrix-destroying enzymes, leading to 
altered tissue integrity [5]. Fibroblast growth fac-
tor-23 (FGF23) was fi rst discovered as an important 
factor for mineral homeostasis [9]. Osteoblastic cells 
can activate hematopoietic cells to differentiate into 
bone resorbing osteoclasts through the production of 
macrophage colony stimulating factor (M-CSF) and 
receptor activator of NFB ligand (RANKL). Lympho-
cytes and malignant cells may also produce M-CSF 
and RANKL, and this may be the cause of excessive 
resorption in infl ammation and cancer. Lining cells 
of osteoblastic origin on the bone surface may also 
play a role by secreting proteolytic enzymes that 
remove a protein layer which normally covers the 
mineralized matrix. 
2. Resorption. Osteoclasts bind to the mineral-
ized matrix through vitronectin receptors and then 
form their resorbing apparatus consisting of a ruffl ed 
border, which secretes hydrogen ions and matrix 
degrading enzymes, particularly Cathepsin K, in a 
compartment that is separated from the extracellular 
fl uid by a sealing zone. This permits the establishment 
of a low pH and a high concentration of enzymes that 
can degrade collagen quite effectively at that low pH. 
In addition to this cellular compartmentalization there 
may be a compartmentalization of the entire bone 
remodeling unit because the lining cells remain intact 
above the osteoclastic resorption and osteoblastic 
formation sites. This might allow for growth factors 
released from osteoclasts or matrix during resorption 
to remain for longer and at more effective concentra-
tions during the next phase. 
3. Reversal. After osteoclastic resorption is com-
plete there is a reversal phase during which mononu-
clear cells, which may be either of the mesenchymal 
or hematopoietic lineage, complete the removal of 
matrix and prepare the bone for formation by laying 
down a “cement line” of non-collagen proteins. 
4. Formation. In the formation phase osteoblasts 
lay down matrix, which becomes gradually mineral-
ized. As each layer of osteoblasts forms its assigned 
amount of matrix it either undergoes apoptosis, or 
becomes buried in the matrix as an osteocyte. As 
this process of replacing the resorption cavity is 
completed, some of the osteoblasts may remain on 
the surface as lining cells [15].
The role of osteoclasts in causing bone loss has 
been studied extensively by many investigators and 
several advances have been made recently. Only a 
few years ago the immune system was linked to bone 
loss and the effects of estrogen in bone metabolism 
were fi rst focused on antagonism of pro-infl ammatory 
cytokines such as IL-1 (interleukin -1), IL-6, TNF-β 
(tumor necrosis factor – β), GM-CSF, and prostaglan-
din E2. These cytokines and prostaglandins were found 
to increase osteoclast proliferation, but estrogens and 
TGF-β were found to decrease the production of these 
cytokines and inhibit osteoclast activation and bone 
resorption [7]. Few studies have examined the age-
related changes in bone composition that may affect 
the functions of the osteoblastic cells. Bone-matrix 
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levels of insulin-like growth factor (IGF)-I and trans-
forming growth factor (TGF)-β determined in bone 
biopsies obtained from donors of various ages, were 
found to decrease with aging. Both IGF-I and TGF-β 
are known to be an important factors controlling hu-
man osteoblast cell proliferation and functions [1]. 
Involvement of IGF-1 in the control of mammalian 
aging was fi rst deduced from increased longevity of 
hypopituitary, growth hormone (GH)-defi cient, and 
GH-resistant mice in which suppression of hepatic 
IGF-1 expression and the resulting in severe reduc-
tion of peripheral IGF-1 levels are prominent shared 
phenotypic characteristics [2]. Also, recent molecular 
approaches have rapidly advanced the fi eld by the 
discovery and extensive characterization of three new 
cytokine systems of the TNF family. They have been 
found to regulate proliferation, differentiation, fusion, 
activation, and apoptosis of osteoclasts. RANKL is nat-
urally inhibited by osteoprotegerin and is important in 
determining the balance of osteoclast activity [6]. This 
system is comprised of a ligand (RANKL) and also its 
specifi c receptor (RANK), as well as decoy receptors 
(OPG). In the case of RANKL, three distinct vari-
ants have been identifi ed: (1) a cell membrane bound 
variant, (2) a soluble form, and (3) another secreted 
form produced by activated T cells, which is found 
to cause rapid bone loss by increasing the activity of 
osteoclasts. This is further supported by showing that 
RANKL gene deletion prevents bone loss and causes 
increased bone mass or osteopetrosis [7].
Osteoclast maturation requires stimulation by 
RANKL expressed on osteoblasts, and cognate inter-
action mediated by fi rm adhesion via inter-cellular 
adhesion molecule (ICAM)-1. Pro-inflammatory 
cytokines such as IL-1 and TNF-β favour bone re-
sorption via the induction of RANKL and ICAM-1 
on osteoblasts. These infl ammatory signals originate 
from the immune system. Ageing is accompanied by 
increased TNF-β, IL-1, RANKL and MCSF expres-
sion and expansion of the osteoclast precursor pool. 
As a consequence, there is an increased stromal/
osteoblastic cell-induced osteoclastogenesis during 
the aging [13].
Bone morphogenetic proteins (BMPs) are mor-
phogens; growth factors and cytokines that belong to 
the transforming growth factor beta (TGFb) super-
family and having a wide range of effects on different 
cell types. Originally identifi ed as protein factors 
able to induce new bone formation ectopically and 
in vivo; their roles in bone and cartilage development 
have been studied extensively. However, their roles 
in development, postnatal growth, homeostasis, and 
diseases extend far beyond the skeletal tissues. [14] 
Bertone and coworkers (2004) stated that, BMP-6 
is thought to be a potent regulator of osteogenic 
differentiation and is being examined for potential 
therapeutic uses in bone tissue engineering [4].
The Cbfa1 (core binding factor alfa1) protein was 
fi rst identifi ed as the nuclear protein that bind to an 
osteoblast specifi c cis-acting element that activates 
the expression of Osteocalcin, an osteoblast-specifi c 
gene. Osteocalcin is noncollagenous bone matrix 
protein that binds to calcium and regulates bone 
formation and mineralization [22].
The newly emerging paradigm in the rapidly de-
veloping fi eld of ‘osteoimmunology’ is that recently 
activated T cells produce several cytokine-like factors, 
such as receptor activator of NFκB ligand (‘RANKL’) 
and TNF-β that exert a dynamic effect on the activity 
of osteoclasts, the bone resorbing cells [5].
In the complex scenario of osteoimmunology, 
the T lymphocyte has the main role. The skeleton is 
physiologically in a state of dynamic equilibrium be-
tween a new bone formation mediated by osteoblasts 
and a resorption mediated by osteoclasts. Both these 
processes are fi nely tuned by cytokines and growth 
factors [13].
It is well known that calcium supplements 
prevent calcium loss in the bone due to estrogen 
defi ciency, because of the variable responses to this 
therapy, several new therapeutic approaches are well 
underway yet. In particular, therapies designed to 
modulate osteoclast activity such as bisphophonates 
and calcitonin, as well as to block signaling of the 
osteoprotegerin (OPG)/receptor activator of nuclear 
factor-κB ligand (RANKL)/RANK pathway, etc. are 
being tried [7].
Emerging molecular evidence suggests that in-
fl ammation also exerts signifi cant infl uence on bone 
turnover. Numerous cytokines and growth factors have 
been implicated in the regulation of osteoblasts and 
osteoclasts. IL-1, IL-6, TNF-, GM-CSF, MCSF, and 
PGE2 have been shown to increase bone resorption 
through indirect or direct modulation of osteoclasts. 
TNF related cytokines have been implicated as media-
tors in the fi nal effectors of cytokine-mediated bone 
resportion. Receptor activator of nuclear factor κB 
ligand (RANKL), osteoprotegerin (OPG), and recep-
tor activator of nuclear factor κB (RANK) have been 
implicated in osteoclast activity in conjunction with 
estrogen, 1,25(OH)2D3, and parathyroid hormone [20].
Apoptosis is a genetically programmed mecha-
nism controlling cell death. Two well-documented 
apoptotic paradigms are the extrinsic and intrinsic 
pathways of apoptosis. The extrinsic pathway, exem-
plifi ed by Fas ligand-induced apoptosis, is achieved 
by sequential activation of initiator and executioner 
caspases without the involvement of mitochondria. 
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The intrinsic pathway is mediated by mitochondria, 
which propagate apoptotic signals by releasing the 
proapoptotic factors such as cytochrome c that acti-
vate downstream executioner caspases [21].
TNF-α also induces osteoblast apoptosis, de-
creasing bone formation. Circulating osteoclast pre-
cursors secrete infl ammatory cytokines amplifying 
infl ammatory circuits at a systemic level [13]. TNF-α 
exert a dynamic effect on the activity of osteoclasts, 
the bone resorbing cells [5] and is closely  linked to 
the activation of osteoclasts, together with prostaglan-
dins  is found to accelerate bone loss [7].
Aging is associated with the phenotypic changes 
in the T-cell compartment and with a decline in T1 
immunity [10] and as a result of imbalanced physi-
ological functions. Both, the decrease and the increase 
of regenerative functions may contribute to/with the 
aging phenotype. In this regard, the bone represents 
an interesting example. In animals, during all period 
of life, the bone mass is maintained dynamically by 
the resorption of existing bones and the formation of 
new ones. With the progress of aging, the activity of 
bone resorption surpasses the activity of bone forma-
tion, which results in aged bone phenotypes such as 
osteoporosis and kyphosis. Recent studies state that the 
inhibition of caspase-2 activity in primary osteoclasts 
signifi cantly increased the viability of these cells [21].
CONCLUSIONS
It is great part of interest to identify the factor 
or factors responsible for impaired osteoblast dif-
ferentiation with aging. It is plausible that several 
circulated factors will be responsible for these effects 
since aging is associated with multitudes of changes 
in serum levels of hormones, growth factors, cyto-
kines, and other serum components known to exert 
signifi cant biological effects on osteoblastic cells. 
For example, insulin-like growth factor-1 (IGF-I), 
transforming growth factor β (TGF-β), interleukin 
(IL)-1, IL-6, and tumor necrosis factor α (TNFα) 
among other factors that are also known to change 
with aging in the bone microenvironment [1]
Many studies were done on animals and that is 
the reason why data cannot be fully contributed to hu-
man beings. Most of them were focused on osteopo-
rosis in relation to bone aging. There are none studies 
done in orthodontics to alveolar bone and bone aging 
with immunohistological methods. It remains largely 
unknown, what kind of molecules can predict pos-
sible tooth movement speed when orthodontic force 
will be applied and what molecules are age-specifi c 
without orthodontic force application. In future, that 
will help to use cell targeted drugs to improve orth-
odontic treatment time and outcome.
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